Survivin is expressed in early hepatocellular carcinoma and surrounding hepatitis tissue

Molecular Medicine Reports

Volumn 2, Issue 6, 2009, Pages 911-915

  Mamori, Satoshi ^a   Matsushima, Masato ^b   Matsuura, Tomokazu ^b   Tajiri, Hisao ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alanine aminotransferase; Hepatitis; Hepatocellular carcinoma; Survivin

Indexed keywords

ALANINE AMINOTRANSFERASE; SURVIVIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EARLY CANCER; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; PATIENT SELECTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; TISSUE SECTION; TREATMENT RESPONSE;

EID: 73649092417     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000191     Document Type: Article

References (27)

1. Parkin DM: International variation. Oncogene 23: 6329-6340, 2004.
2. Hiraoka A, Kumagi T, Hirooka M, Uehara T, Kurose K, Iuchi H, Hiasa Y, Matsuura B, Michitaka K, Kumano S, Tanaka H, Yamashita Y, Horiike N, Mochizuki T and Onji M: Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment. World J Gastroenterol 12: 2075-2079, 2006.
3. Ye CP, Qiu CZ, Huang ZX, Su QC, Zhuang W, Wu RL and Li XF: Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma. World J Gastroenterol 13: 6264-6268, 2007.
4. Altieri DC and Marchisio PC: Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79: 1327-1333, 1999.
5. Giodini A, Kallio MJ, Wall NR, Gorbsky GJ, Tognin S, Marchisio PC, Symons M and Altieri DC: Regulation of microtubule stability and mitotic progression by survivin. Cancer Res 62: 2462-2467, 2002.
6. Wakana Y, Kasuya K, Katayanagi S, Tsuchida A, Aoki T, Koyanagi Y, Ishii H and Ebihara Y: Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep 9: 1213-1218, 2002.
7. Lu M, Kwan T, Yu C, Chen F, Freedman B, Schafer JM, Lee EJ, Jameson JL, Jordan VC and Cryns VL: Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest. J Biol Chem 280: 6742-6751, 2005.
8. Tarnawski A, Pai R, Chiou SK, Chai J and Chu EC: Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B. Biochem Biophys Res Commun 334: 207-212, 2005.
9. Kania J, Konturek SJ, Marlicz K, Hahn EG and Konturek PC: Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci 48: 266-271, 2003.
10. Zhu XD, Lin GJ, Qian LP and Chen ZQ: Expression of survivin in human gastric carcinoma and gastric carcinoma model of rats. World J Gastroenterol 9: 1435-1438, 2003.
11. Ikeguchi M, Liu J and Kaibara N: Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment. Apoptosis 7: 23-29, 2002.
12. Zaffaroni N, Pennati M and Daidone MG: Survivin as a target for new anticancer interventions. J Cell Mol Med 9: 360-372, 2005.
13. Mamori S, Asakura T, Ohkawa K and Tajiri H: Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition. World J Gastroenterol 13: 5306-5311, 2007.
14. Span PN, Tjan-Heijnen VC, Heuvel JJ, De Kok JB, Foekens JA and Sweep FC: Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer? Clin Chem 52: 1693-1700, 2006.
15. Ikeguchi M and Kaibara N: Survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. Br J Cancer 87: 883-887, 2002.
16. Miyachi K, Sasaki K, Onodera S, Taguchi T, Nagamachi M, Kaneko H and Sunagawa M: Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer 6: 217-224, 2003.
17. Sarela AI, Scott N, Ramsdale J, Markham AF and Guillou PJ: Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 8: 305-310, 2001.
18. Ryan B, O'Donovan N, Browne B, O'Shea C, Crown J, Hill AD, McDermott E, O'Higgins N and Duffy MJ: Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer. Br J Cancer 92: 120-124, 2005.
19. Sarela AI, Verbeke CS, Ramsdale J, Davies CL, Markham AF and Guillou PJ: Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer 86: 886-892, 2002.
20. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC and Altieri DC: Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 97: 13103-13107, 2000.
21. Fukuda S, Mantel CR and Pelus LM: Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. Blood 103: 120-127, 2004.
22. Rosa J, Canovas P, Islam A, Altieri DC and Doxsey SJ: Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. Mol Biol Cell 17: 1483-1493, 2006.
23. Nakahara T, Takeuchi M, Kinoyama I, Minematsu T, Shirasuna K, Matsuhisa A, Kita A, Tominaga F, Yamanaka K, Kudoh M and Sasamata M: YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 67: 8014-8021, 2007.
24. Altieri DC: Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22: 8581-8589, 2003.
25. Waris G and Siddiqui A: Regulatory mechanism of viral hepatitis B and C. J Biosci 28: 311-321, 2003.
26. Kountouras J, Zavos C and Chatzopoulos D: Apoptosis in hepatitis C. J Viral Hepat 10: 335-342, 2003.
27. Green RM and Flamm S: AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 123: 1367-1384, 2002.